MicrobiologybioRxivPreprint
Intranasal delivery of lipid nanoparticle encapsulated SARS-CoV-2 and RSV-targeting siRNAs reduces lung infection
A. Supramaniam, Y. Tayyar, D. T. Clarke…·A. Idris
This paper develops an intranasal lipid nanoparticle (LNP) delivery system for siRNAs targeting SARS-CoV-2 and RSV, showing effective reduction of lung infection in mice.
DOI 10.1101/2022.07.25.501479